Breakthrough Study Reveals Rapid Reduction of Gout-Related Crystal Deposits with Pegloticase Therapy
A new study found that Monosodium urate (MSU) crystal deposits, detectable with dual-energy CT (DECT), diminish rapidly during pegloticase treatment, particularly when co-administered with methotrexate (MTX) for uncontrolled gout. The volume of MSU crystals also slowed or stopped even when SU was maintained at <6mg/dL with oral ULT. The study findings were published in the […]